Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)
1 clinical trials · Condition
◉ Watch Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)
| Record | Firm | Date |
|---|---|---|
| Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults. (NCT05226702) | University of Saskatchewan | 2022-07-22 |
Track Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group) automatically
Every clearance here is in the API, with alerts when new ones post.